EUVIMEDObjevte EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC 4.0

On the role of antibody affinity and avidity in the IgE ‐mediated allergic response

Martin F Bachmann iD, Pascal S Krenger iD, Mona O Mohsen iD, Matthias F Kramer iD, Sviatlana Starchenka iD, Piers Whitehead, Monique Vogel iD, Matthew D Heath iD

Allergy · 2025-01 · 80 (1) · 37-46

DOI: 10.1111/all.16248 ↗

At a glance

Übersichtsarbeit in Allergy, published online on 2024-08-27. Written by Martin F Bachmann and 7 co-authors. Institution: Department of Rheumatology and Immunology, University Hospital of Bern, Bern, Switzerland. Major MEDLINE topics: Immunoglobulin E, Antibody Affinity, Hypersensitivity, Basophils. Cited 18 times so far (Crossref); 69 references. The full text is freely available (open access, CC BY-NC 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Type I hypersensitivity, also known as classical allergy, is mediated via allergen‐specific IgE antibodies bound to type I FcR (FcεRI) on the surface of mast cells and basophils upon cross‐linking by allergens. This IgE‐mediated cellular activation may be blocked by allergen‐specific IgG through multiple mechanisms, including direct neutralization of the allergen or engagement of the inhibitory receptor FcγRIIb which blocks IgE signal transduction. In addition, co‐engagement of FcεRI and FcγRIIb by IgE‐IgG‐allergen immune complexes causes down regulation of receptor‐bound IgE, resulting in desensitization of the cells. Both, activation of FcεRI by allergen‐specific IgE and engagement of FcγRIIb by allergen‐specific IgG are driven by allergen‐binding. Here we delineate the distinct roles of antibody affinity versus avidity in driving these processes and discuss the role of IgG subclasses in inhibiting basophil and mast cell activation.

Subjects

MeSH terms (MEDLINE)

Immunoglobulin EAntibody AffinityHypersensitivityBasophilsReceptors, IgEMast CellsHumansAnimalsImmunoglobulin GAllergensReceptors, IgG

Author keywords

IgEaffinityallergyantibodyavidity

Substances

Immunoglobulin EReceptors, IgEImmunoglobulin GAllergensReceptors, IgG

Authors and institutions

  • Department of Rheumatology and Immunology, University Hospital of Bern, Bern, Switzerland.
  • Department for Biomedical Research Bern (DBMR), University of Bern, Bern, Switzerland.
  • Nuffield Department of Medicine, The Jenner Institute, University of Oxford, Oxford, UK.
  • Allergy Therapeutics, Worthing, UK.
  • Bencard Allergie GmbH, Munich, Germany.
  • SeromYx Systems, Cambridge, Massachusetts, USA.

ORCID profiles: Martin F Bachmann, Pascal S Krenger, Mona O Mohsen, Matthias F Kramer, Sviatlana Starchenka, Monique Vogel, Matthew D Heath

Cite

APA

Bachmann, M. F., Krenger, P. S., Mohsen, M. O., Kramer, M. F., Starchenka, S., Whitehead, P., Vogel, M., & Heath, M. D. (2025). On the role of antibody affinity and avidity in the IgE ‐mediated allergic response. Allergy, 80(1), 37-46. https://doi.org/10.1111/all.16248

Vancouver

Bachmann MF, Krenger PS, Mohsen MO, Kramer MF, Starchenka S, Whitehead P, et al. On the role of antibody affinity and avidity in the IgE ‐mediated allergic response. Allergy. 2025;80(1):37-46. doi:10.1111/all.16248

BibTeX
@article{Bachmann2025,
  author = {Bachmann, Martin F and Krenger, Pascal S and Mohsen, Mona O and Kramer, Matthias F and Starchenka, Sviatlana and Whitehead, Piers and Vogel, Monique and Heath, Matthew D},
  title = {On the role of antibody affinity and avidity in the IgE ‐mediated allergic response},
  journal = {Allergy},
  year = {2025},
  volume = {80},
  number = {1},
  pages = {37--46},
  doi = {10.1111/all.16248}
}
Start for free →